2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

MAY 21 23 Posters Monday Afternoon Morning PO-327: PO-328: PO-329: PO-330: Effect of Lifestyle Modification in Menopausal Women with Obesity, Hypertension, Autonomic and Endothelial Dysfunction Rosa M. Santos, 1 Joao Freitas, 1 Agostinho Monteiro, 3 Espiga Macedo, 3 Eduardo Tejera, 2 Irene Rebelo. 2 1 Hospital S Joao, Porto, PT; 2 Faculty Pharmacy, Porto, PT; 3 Faculty Medicine, Porto, PT. At Risk Older Latino Men and Women: Blood Pressure, Body Mass Index and DASH Accordance Beth A. Staffileno, 1 Christy Tangney, 1 David X. Marquez, 2 Louis Fogg, 1 Eduardo E. Bustamante, 2 Martha Clare Morris, 1 Ruby Hoyem, 1 Alexis Manning, 1 JoEllen Wilbur. 1 1 Rush University Medical Center, Chicago, IL, US; 2 University of Illinois at Chicago, Chicago, IL, US. Medical Avatar Can Select Patients with Cardiovascular Risk Factors Jerzy T. Tyszkiewicz, Bartosz Symonides, Zbigniew Gaciong. Medical University of Warsaw, Warsaw, PL. Aerobic Exercise Training Improves Endothelial Function in Pre-Hypertensive African Americans Sheara T. Williamson, Deborah L. Feairheller, Kathleen M. Sturgeon, Praveen Veerabhadrappa, Michael D. Brown, Jan Kretzschmar. Temple University, Philadelphia, PA, US. Obesity PO-331: PO-332: PO-334: PO-335: The Effect of BMI on the Systemic Catecholamine and Haemodynamic Response to Increased Sympathetic Activity in Young Adults: A Pilot Study James M. Coulson†, John R. Cockcroft. Cardiff University, Cardiff, Wales, GB. Aldosterone Release is Positively Correlated with Increasing Body Weight in Patients with Resistant Hypertension Tanja Dudenbostel, Maria Czarina Acelajado, Roberto Pisoni, Suzanne Oparil, David A. Calhoun. Vascular Biology and Hypertension, University of Alabama at Birmingham, Birmingham, AL, US. Beta2-Adrenoceptor Polymorphisms (Arg16Gly) Accompanying High Plasma Norepinephrine is Related to Cardiovascular and Renal Complications in Obese Subjects Kazuko Masuo, 1 Hiromi Rakugi, 2 Toshio Ogihara, 2 Murray D. Esler, 1 Gavin W. Lambert. 1 1 Baker IDI Heart & Diabetes Institute, Melbourne, VIC, AU; 2 Osaka University Graduate School of Medicine, Suita, Osaka, JP. Efficacy of an Amlodipine/Olmesartan Medoxomil Algorithm on BP Control in Obese Patients Uncontrolled by Monotherapy Joel M. Neutel†, 1 Willa Hsueh, 2 Ali Shojaee, 3 William F. Waverczak, 3 Jen‐Fue Maa. 3 1 Orange County Research Center, US; 2 The Methodist Hospital Research Institute, US; 3 Daiichi Sankyo, Inc., US. 138
Monday Morning Afternoon MAY 21 23 Posters PO-336: PO-337: PO-338: PO-339: Resolution of Hypertension after Adjustable Gastric Banding – 1 Year Interim Results of the LAP-BAND AP® EXperience (APEX) Study John Dixon, 1 Michael Oefelein, 2 Ted Okerson†. 2 1 Monash University, Melbourne, AU; 2 Allergan, Inc, Irvine, CA, US. Initial Aliskiren/HCTZ Combination Therapy Lowers BP in Obese Patients with Stage 2 Hypertension and Type 2 Diabetes Raymond R. Townsend, 1 Alan Forker, 2 Thomas Severin, 3 Cheraz Cherif Papst, 3 Anthony Yadao. 4 1 University of Pennsylvania Medical Center, Philadelphia, PA, US; 2 St Luke’s Lipid and Diabetes Research Center, Kansas City, MO, US; 3 Novartis Pharma AG, Basel, CH; 4 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US. Aliskiren/HCTZ Inhibits RAAS Activity in Obese and Non-Obese Patients with Stage 2 Hypertension and Type 2 Diabetes Raymond R. Townsend, 1 Alan Forker, 2 Thomas Severin, 3 Cheraz Cherif Papst, 3 Anthony Yadao. 4 1 University of Pennsylvania Medical Center, Philadelphia, PA, US; 2 St Luke’s Lipid and Diabetes Research Center, Kansas City, MO, US; 3 Novartis Pharma AG, Basel, CH; 4 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US. Aliskiren/Amlodipine Combination Lowers BP in Obese and Non-Obese Patients with Moderate-to- Severe Hypertension Rudiger C. Braun‐Dullaeus, 1 Sergey B. Shustov, 2 Carmen Alvarez, 3 Gregorio G. Rogelio, 4 Cheraz Cherif Papst, 5 Jack Zhang†. 6 1 Otto-von-Guericke University, Magdeburg, DE; 2 State Educational Institution of High Professional Education, St Petersburg, RU; 3 ABS Centelles, Barcelona, ES; 4 St Luke’s Medical Center, Quezon, PH; 5 Novartis Pharma AG, Basel, CH; 6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US. Patient-Provider-Healthcare System Issues PO-340: PO-341: Clinical Inertia in Hypertension: Identifying Barriers to Improve Quality Bryan Batson, 1 JaNae Joyner, 2 Philip Mellen, 1 William Smith. 1 1 Hattiesburg Clinic, Hattiesburg, PA, US; 2 The Consortium for Southeastern Hypertension Control (COSEHC), Winston-Salem, NC, US. Renal Artery Stent Management: A Survey of Local Practice Patterns Frank K. Boateng, Daniel L. Landry, Barbara A. Greco. Baystate Medical Center, Springfield, MA, US. 139
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65:
MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67:
MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69:
MAY 23 Sessions Monday morning 8:00
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
MAY 23 Plenary Session II Monday Af
Page 80 and 81:
MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90: Saturday Afternoon MAY 21 Posters 4
Page 91 and 92: Saturday Afternoon MAY 21 Posters P
Page 93 and 94: Saturday Afternoon MAY 21 Posters E
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 139: Monday Morning Afternoon MAY 21 23
Page 147 and 148: Faculty Disclosure Listing Rajiv Ag
Page 149 and 150: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166: 2011 ASH Exhibitors continued Inter
Page 167 and 168: 2011 ASH Exhibitors continued Novar
Page 169 and 170: 2011 ASH Exhibitors continued Wiley
Page 171 and 172: Author Index Berezina, Aelita V., 8
Page 173 and 174: Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176: Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178: Author Index Makani, Harikrishna, 1
Page 179 and 180: Author Index Rabelink, Ton J., 93 R
Page 181 and 182: Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184: Hilton New York Floor Plans Second
Page 185 and 186: Hilton New York Floor Plans Fourth
Page 187 and 188: Tekamlo (aliskiren and amlodipine)
Page 189 and 190: 25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

Create successful ePaper yourself

Delete template?

Save as template?